Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $27.230.00 (0.00%)07/19/17 4:00 p.m. ET
Stock chart for: ANAB.O.  Currently trading at $27.23 with a 52 week high of $29.96 and a 52 week low of $15.17.
Data provided by Nasdaq. Minimum 15 minutes delayed.




Upcoming Events


  |   |   |   |   |